Press release
Automated Compounding Devices Market is expected to reach USD 2.3 billion by 2034
Automated Compounding Devices
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71627
The global healthcare industry is rapidly adopting automation to meet the rising demand for complex therapies, streamline workflows, and improve patient outcomes. As the burden of chronic diseases increases and personalized medicine grows, the automated compounding devices market is set to expand steadily over the next decade.
Market Overview
The global automated compounding devices market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.3 billion by 2034, growing at a CAGR of 7% during the forecast period.
Key Highlights:
• Increasing demand for sterile, accurate, and safe compounding of IV drugs.
• Rising incidence of cancer and chronic diseases driving adoption in oncology and nutrition support.
• Growing focus on reducing medication errors through automation.
• Investments in smart technologies and connectivity features for real-time monitoring.
• Challenges include high device costs, maintenance requirements, and adoption barriers in low-resource settings.
Leading Players include Becton Dickinson (BD), Baxter International, ICU Medical, Omnicell, Grifols, ARxIUM, and B. Braun Melsungen, who are innovating to expand their global footprint in compounding automation.
Segmentation Analysis
By Product
• Chemotherapy Compounding Devices
• Parenteral Nutrition Compounding Devices
• Other IV Drug Compounding Devices
By Platform
• Standalone Automated Compounding Systems
• Integrated Pharmacy Automation Platforms
• Cloud-Connected Compounding Solutions
By Technology
• Robotic Compounding Systems
• Gravimetric & Volumetric Dosing Technologies
• Barcode & RFID-Based Verification
• AI & Workflow Management Software
By End Use
• Hospitals & Oncology Centers
• Compounding Pharmacies
• Ambulatory Surgical Centers
• Research & Academic Institutes
By Application
• Chemotherapy Drug Preparation
• Parenteral Nutrition (PN)
• Pain Management Therapies
• Other High-Risk IV Medications
Summary:
The market is strongly driven by chemotherapy and parenteral nutrition compounding, where precision and sterility are critical. Integration with digital platforms and robotic technologies will shape future growth, particularly in hospital and specialty pharmacy environments.
Explore Full Report here: https://exactitudeconsultancy.com/reports/71627/automated-compounding-devices-market
Regional Analysis
North America
• Largest share due to advanced hospital infrastructure, high oncology drug usage, and strong regulatory emphasis on medication safety.
• U.S. leads with rapid adoption of robotic compounding solutions.
Europe
• Strong adoption of sterile compounding automation supported by stringent safety standards.
• Germany, France, and the UK drive demand for advanced robotic pharmacy solutions.
Asia-Pacific
• Fastest-growing region, driven by expanding healthcare infrastructure and rising cancer prevalence.
• China, India, and Japan are key growth markets investing in automation and pharmacy modernization.
Middle East & Africa
• Smaller but gradually expanding market.
• Growth supported by healthcare digitization and increasing investments in oncology care.
Latin America
• Moderate growth, with Brazil and Mexico leading adoption of automated compounding technologies.
• Increasing focus on medication safety in regional hospital systems.
Summary:
While North America and Europe dominate today's market, Asia-Pacific is expected to achieve the highest CAGR from 2024 to 2034, driven by demographic shifts, rising healthcare investments, and growing oncology demand.
Market Dynamics
Growth Drivers
• Rising incidence of cancer and chronic diseases requiring IV drug therapies.
• Increasing regulatory pressure to reduce medication errors.
• Growing adoption of personalized and complex medication regimens.
• Integration of smart technologies for real-time monitoring and quality assurance.
Challenges
• High upfront costs and maintenance of automated compounding devices.
• Limited adoption in small- and mid-sized hospitals due to budget constraints.
• Technical challenges in handling diverse drug formulations.
Latest Trends
• Adoption of robotic compounding systems for oncology drug preparation.
• Integration of AI and machine learning for predictive error detection.
• Cloud-based solutions for remote monitoring and compliance tracking.
• Expansion of pharmacy automation platforms integrating ACDs with inventory and dispensing systems.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71627
Competitive Landscape
Key Market Players:
• Becton Dickinson (BD)
• Baxter International Inc.
• ICU Medical, Inc.
• Omnicell, Inc.
• Grifols, S.A.
• ARxIUM Inc.
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Swisslog Healthcare
• Medline Industries
Competition is driven by technological innovation, regulatory compliance, and global expansion. BD and Baxter lead the market with established portfolios, while ICU Medical, Omnicell, and Grifols continue to innovate in robotic and cloud-enabled compounding solutions. Strategic partnerships and acquisitions are common as players seek to expand their geographic presence and enhance product capabilities.
Conclusion
The automated compounding devices market is entering a decade of steady growth, supported by the global push for medication safety, workflow efficiency, and precision in compounding high-risk drugs. With the global market projected to expand at a CAGR of 7% from 2024 to 2034, opportunities abound for both established players and new entrants.
Key opportunities include:
• Wider adoption of robotic compounding in oncology and parenteral nutrition.
• Integration of cloud-based monitoring and AI-driven automation.
• Development of cost-effective solutions for emerging markets.
• Strongest growth potential in Asia-Pacific, driven by healthcare modernization and oncology demand.
As hospitals and pharmacies continue to prioritize safety, efficiency, and compliance, automated compounding devices will remain at the center of pharmacy automation, offering strong growth potential across all major regions.
This report is also available in the following languages : Japanese (自動調合装置市場), Korean (자동 배합 장치 시장), Chinese (自动配混设备市场), French (Marché des dispositifs de composition automatisés), German (Markt für automatisierte Compoundiergeräte), and Italian (Mercato dei dispositivi di compounding automatizzati), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71627/automated-compounding-devices-market#request-a-sample
Our More Reports:
Schizophrenia Market
https://exactitudeconsultancy.com/reports/72064/schizophrenia-market
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market
https://exactitudeconsultancy.com/reports/72065/nucleic-acid-and-gene-therapies-in-neuromuscular-disorders-market
Opioid Overdose Market
https://exactitudeconsultancy.com/reports/72066/opioid-overdose-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Automated Compounding Devices Market is expected to reach USD 2.3 billion by 2034 here
News-ID: 4173771 • Views: …
More Releases from Exactitude Consultancy
Esophageal Cancer Patient Pool Analysis Market Insights and Future Outlook
Introduction
Esophageal cancer is one of the most lethal gastrointestinal malignancies, ranking among the top ten causes of cancer-related deaths globally. The disease is primarily classified into two subtypes: squamous cell carcinoma (ESCC) and adenocarcinoma (EAC). Both subtypes have distinct geographical prevalence patterns, risk factors, and treatment responses, creating a complex and evolving market landscape.
The esophageal cancer patient pool analysis market plays a vital role in understanding treatment demand, patient demographics,…
Pheochromocytomas and Paragangliomas (PPGL) Market to Set Phenomenal Growth From …
Pheochromocytomas and Paragangliomas (PPGL) Market Outlook 2024-2034: Rising Awareness and Targeted Therapies Drive Growth
Introduction
Pheochromocytomas and paragangliomas (collectively known as PPGL or PCPG) are rare neuroendocrine tumors that originate from chromaffin cells in the adrenal medulla or extra-adrenal paraganglia. While pheochromocytomas arise in the adrenal glands, paragangliomas occur in various parts of the body including the abdomen, chest, and head-and-neck region.
Although rare, these tumors can be life-threatening if untreated, often associated…
Anaplastic Large Cell Lymphoma (ALCL) Market New Product Development & Latest Tr …
Introduction
Anaplastic large cell lymphoma (ALCL) is a rare and aggressive subtype of non-Hodgkin's lymphoma (NHL) that arises from T-cells. ALCL accounts for a small proportion of lymphomas but is clinically significant due to its aggressive nature and the availability of unique therapeutic pathways, such as targeting the anaplastic lymphoma kinase (ALK) protein in ALK-positive cases.
Over the past decade, major breakthroughs in targeted therapies, monoclonal antibodies, and immunotherapy have transformed the…
Sezary Syndrome (SS) Market 2025-2034 Business Outlook, Critical Insight and Gro …
Introduction
Sezary syndrome (SS) is a rare and aggressive form of cutaneous T-cell lymphoma (CTCL), characterized by the presence of malignant T-lymphocytes in the blood, skin, and lymph nodes. Patients often present with erythroderma, lymphadenopathy, and circulating atypical cells, making management complex. Due to its rarity and poor prognosis, SS represents a significant unmet need in oncology.
In recent years, advances in targeted therapies, monoclonal antibodies, and immunomodulators have provided new hope…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
